IA promotes PSMB5 expression in an Nrf2-dependent manner, inhibits mitochondrial fission, and ameliorates endothelial dysfunction. It lays the foundation for the future development of IA as a drug for the prevention and treatment of AS. This evidence concerns the gene PSMB5 and endothelial dysfunction.